From: Quality of gout care in the emergency departments: a multicentre study
Items/recommendations | Total N (%) (n = 632) | Definite gouta N (%) (n = 266) | ICD-10 N (%) (n = 366) |
---|---|---|---|
Investigations in EDs | |||
- Complete blood count** | 265 (41.9) | 152 (57.1) | 113 (30.9) |
- Renal function test** | 302 (47.8) | 161 (60.5) | 141 (38.5) |
Arthrocentesis** | 185 (29.3) | 161 (60.5) | 24 (6.6) |
Consultation** | 157 (24.8) | 105 (39.5) | 52 (14.2) |
Average time in EDs**, hour, mean (±SD) | 2.16 (2.16) (n = 369) | 3.05 (2.72) (n = 162) | 1.46 (1.19) (n = 207) |
Monotherapy of colchicine | |||
- In EDs* | 167/628 (26.6) | 93/265 (35.1) | 74/363 (20.4) |
- In HM* | 186/519 (35.8) | 91/204 (44.6) | 95/315 (30.2) |
NSAIDsb can be used in early or late treatment of GF. | |||
- In EDs* | 343/628 (54.6) | 121/265 (45.7) | 222/363 (61.2) |
NSAIDsb should be used in normal renal function. | |||
- In EDs* | 183/343 (53.4) | 85/121 (70.5) | 98/222 (44.1) |
NSAIDsb were used in unevaluated renal function. | |||
- In EDs** | 118/343 (34.4) | 21/121 (17.4) | 97/222 (43.7) |
- In HM* | 95/276 (34.4) | 17/96 (17.7) | 78/180 (43.3) |
All patients who have improved after acute GF should have an appointment to follow up for evaluation of the risks or factors that can affect SUA and to evaluate complication of gout disease*. | 436/632 (69.0) | 216/266 (81.2) | 220/366 (60.1) |